复杂干预的开发与评价:2021年英国医学研究委员会框架更新解读  

A new framework for developing and evaluating complex interventions: interpretation of the 2021 update of Medical Research Council framework

作　　者：赵燕利[1] 李莹莹[2] 李秋芳[1] 汪晓凯[1] 刘腊梅[1] ZHAO Yanli;LI Yingying;LI Qiufang;WANG Xiaokai;LIU Lamei(School of Nursing and Health,Zhengzhou University,Zhengzhou 450001,P.R.China;Department of Hematology,Henan Provincial Peoples Hospital,Zhengzhou 450003,P.R.China)

机构地区：[1]郑州大学护理与健康学院,郑州450001 [2]河南省人民医院血液内科,郑州450003

出　　处：《中国循证医学杂志》2023年第2期125-132,共8页Chinese Journal of Evidence-based Medicine

基　　金：河南省教育厅2023年人文社会科学研究项目(编号:2023-ZDJH-207);河南省社科联2022年调研项目(编号:SKL-2022-537)。

摘　　要：复杂干预在医疗、护理、公共卫生及对健康有影响的其他社会和经济政策领域都有着广泛应用。而复杂干预在组成部分、作用机制、涉及人群及与实施情境间的相互作用等方面存在诸多的复杂性,如何对复杂干预进行开发与评价就显得尤为重要。英国医学研究委员会发布的复杂干预开发与评价框架为这一过程提供了纲领性指导,本文对该框架的更新过程和新版框架的重点内容进行介绍和解读,以期为国内研究者开发和评价复杂干预提供参考和借鉴。Complex interventions are commonly used in health and social care services, public health practice,and other areas of social and economic policy that have consequences for health. Due to the multiple components of interventions, the complicated mechanisms of change, the diversity of the population involved, and the interaction between the intervention and the context in which it is implemented, the appropriate development and evaluation of complex interventions has become increasingly critical. The UK Medical Research Council published a framework for developing and evaluating complex interventions. The aim of this article is to introduce and interpret the framework to provide guidance on the development and evaluation of complex interventions for domestic researchers.

关 键 词：复杂干预 开发 评价 

分 类 号：R-03[医药卫生]